Diabetes complications

The resistive and pulsatility indices of the dorsal metatarsal artery for the screening of peripheral lower artery disease in patients with and without diabetes

Diabetes Res Clin PractPublished Diagnostic accuracy study

Authors' conclusion

Dorsal metatarsal artery resistive index (MARI) showed a significant inverse correlation with PAD, similarly to ABI, irrespective of the presence of diabetes. MARI seems to be an effective screening tool for PAD even in patients with wall calcification. Further studies are needed for confirming the results of the present pilot study.

Study context

Population
Patients with and without diabetes assessed for lower extremity peripheral artery disease (PAD); 21 (65.6 %) with diabetes51 legs
Participants
32 patients
Comparison
Resistive and pulsatility indices of the dorsal metatarsal artery vs ankle-brachial index (ABI)
Outcome
Correlation between PI, RI and ABI
Methodological detailspilot study
  • Pilot study

Performance

As reported in the abstract

Association of DMA RI and PI with PAD and correlation with ABI
PAD significantly associated with lower resistive (RI) and pulsatility index (PI) of the dorsal metatarsal artery (DMA)
both p < 0.000
RI, but not PI, correlated significantly with ABI when ABI <1.4, but not when ABI >1.4
r = 0.535

Further findings

Patients with diabetes

Similar figure vs those without diabetes; RI, but not PI, correlated significantly with ABI
r = 0.600

ABI not calculable due to wall calcification

Legs with ABI not calculable
14 legs (27.5 %)
Legs with compressible arteries
37 (72.5 %)

Original publication

The resistive and pulsatility indices of the dorsal metatarsal artery for the screening of peripheral lower artery disease in patients with and without diabetes. Diabetes Res Clin Pract. Published 3 June 2024. doi:10.1016/j.diabres.2024.111732

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.